Detalhe da pesquisa
1.
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis.
N Engl J Med
; 354(9): 911-23, 2006 Mar 02.
Artigo
Inglês
| MEDLINE | ID: mdl-16510745
2.
Health-related quality of life in multiple sclerosis: effects of natalizumab.
Ann Neurol
; 62(4): 335-46, 2007 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-17696126
3.
Clinical management of multiple sclerosis: the treatment paradigm and issues of patient management.
J Manag Care Pharm
; 10(3 Suppl B): S19-25, 2004 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-15253686
4.
Stepped-care approach to treating MS: a managed care treatment algorithm.
J Manag Care Pharm
; 10(3 Suppl B): S26-32, 2004 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-15253687
5.
Additional efficacy endpoints from pivotal natalizumab trials in relapsing-remitting MS.
J Neurol
; 259(5): 898-905, 2012 May.
Artigo
Inglês
| MEDLINE | ID: mdl-22008873
6.
Efficacy of natalizumab therapy in patients of African descent with relapsing multiple sclerosis: analysis of AFFIRM and SENTINEL data.
Arch Neurol
; 68(4): 464-8, 2011 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-21482925
7.
Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis.
J Neurol Sci
; 292(1-2): 28-35, 2010 May 15.
Artigo
Inglês
| MEDLINE | ID: mdl-20236661
8.
The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL.
J Neurol
; 256(3): 405-15, 2009 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-19308305
9.
Combination therapy for the treatment of multiple sclerosis: challenges and opportunities.
Curr Med Res Opin
; 23(6): 1199-208, 2007 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-17559719
10.
Concomitant therapy for multiple sclerosis.
Neurology
; 63(11 Suppl 5): S28-34, 2004 Dec 14.
Artigo
Inglês
| MEDLINE | ID: mdl-15596733
11.
Selecting a disease-modifying agent as platform therapy in the long-term management of multiple sclerosis.
Neurology
; 63(11 Suppl 5): S19-27, 2004 Dec 14.
Artigo
Inglês
| MEDLINE | ID: mdl-15596732